E. Rankin

发表

Phase I clinical and pharmacokinetic study of LY 195448

S. Kaye, J. Cassidy, C. Lewis, 2004, Cancer Chemotherapy and Pharmacology.

Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodies.

W. W. ten Bokkel Huinink, A. Hekman, E. Rankin, 1985, Blood.

A mathematical model of the development of drug resistance to cancer chemotherapy.

S Gallivan, R. Rubens, B. Birkhead, 1987, European journal of cancer & clinical oncology.

Scientific aspects of gene therapy in melanoma

E. Rankin, 1995, Current opinion in oncology.

Reply to the letter from Janssen et al

L. T. Vlasveld, C. Melief, E. Rankin, 1994, British Journal of Cancer.

Overcoming CYP1A1/1A2 mediated induction of metabolism by escalating erlotinib dose in current smokers.

D. Dunlop, A. Price, M. Nicolson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.

D. Cruickshank, S. M. Crawford, S. Kaye, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide

R. V. Valdés Olmos, C. Hoefnagel, E. Rankin, 2004, European Journal of Nuclear Medicine.

A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix

R. Souhami, M. Slevin, R. Coleman, 2004, Cancer Chemotherapy and Pharmacology.

Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer

M. Highley, L. Campbell, E. Rankin, 2007, International Journal of Gynecologic Cancer.

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

H. van Tinteren, H. Tinteren, J. Wagstaff, 1993, British Journal of Cancer.

Metastatic vipoma arising from colonic primary tumour.

G. Haddock, E. Rankin, C. Bradley, 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.

G. Brittinger, D. Huhn, U. Jaeger, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3

N. Cascinelli, J. Naeyaert, J. Canon, 1995, International journal of cancer.

A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study.

H. Keizer, J. Verweij, R. Sylvester, 1989, European journal of cancer & clinical oncology.

IN SILICO AND IN VITRO SCREENING FOR INHIBITION OF CYTOCHROME P450 CYP3A4 BY COMEDICATIONS COMMONLY USED BY PATIENTS WITH CANCER

Gordon C K Roberts, Simon J Brown, C Roland Wolf, 2006, Drug Metabolism and Disposition.

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects.

A. C. Dubbelman, S. Rodenhuis, J. Beijnen, 1992, British Journal of Cancer.

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.

S. Rodenhuis, J. Sein, A. Hekman, 1993, British Journal of Cancer.

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE‐3 and presented by HLA‐A1

P. Coulie, Y. Humblet, B. Dréno, 1999, International journal of cancer.

Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough

R. Booton, J. Smith, A. Morice, 2010, Cough.

Radioimmunodetection of cancer: problems and potential.

J. Mcvie, E. Rankin, 1983, British medical journal.

A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer.

D. Cruickshank, S. Kaye, S. Kaye, 1992, British Journal of Cancer.

A phase Istudy ofprolonged continuous infusion oflowdoserecombinant interleukin-2 inmelanoma andrenal cellcancer.PartI:clinical aspects

A. C. Dubbelman, S. Rodenhuis, J. Beijnen, 1992 .

Reconstitution of interleukin-2

S. Rodenhuis, A. Hekman, E. Rankin, 1990, The Lancet.

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

D. Cruickshank, S. M. Crawford, S. Kaye, 1992, The Lancet.

Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.

R. K. Knight, R. Rubens, E. Rankin, 1987, Cancer treatment reports.

Phase I and pharmacokinetic study of intraperitoneal thioTEPA in patients with ovarian cancer

D. Kerr, S. Kaye, J. Cassidy, 2008, Cancer Chemotherapy and Pharmacology.

Carboplatin-based combination chemotherapy for advanced carcinoma of the cervix

S. Kaye, N. Reed, J. Paul, 2004, Cancer Chemotherapy and Pharmacology.

IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer.

L. Thomsen, C. Hack, A. Ogilvie, 1996, Journal of immunology.

Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist.

W. Rapeport, S. Kaye, J. Cassidy, 1988, British Journal of Cancer.

Treatment of invasive thymoma with single-agent ifosfamide.

M. Highley, C. Karapetis, B. Bryant, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

STAGTING PATIENTS WITH NON‐HODGKIN'S LYMPHOMA

D. Crowther, E. Rankin, D. Crowther, 1982 .

Phase I and pharmacokinetic study of flavone acetic acid.

D. Kerr, S. Kaye, J. Cassidy, 1987, Cancer research.

Mouse monoclonal antibodies against the idiotype of human B cell non‐Hodgkin lymphomas: production, characterization and use to monitor the progress of disease

A. Hekman, E. Rankin, Annemarie Hekman, 1984, European journal of immunology.

Possible role for cytotoxic lymphocytes in the pathogenesis of acute interstitial nephritis after recombinant interleukin-2 treatment for renal cell cancer

C. Figdor, J. Sein, A. Hekman, 2005, Cancer Immunology, Immunotherapy.

Immunosuppression and oncology

J. Mcvie, E. Rankin, 1985 .

The myelotoxicity of carboplatin is influenced by the time of its administration

D. Kerr, S. Kaye, D. Newell, 1990, Hematological oncology.

Treatment of Human B Cell Lymphoma with Monoclonal Anti-Idiotype Antibodies

A. Hekman, E. Rankin, 1986 .

Therapeutic use of monoclonal anti-idiotype antibodies against B-cell lymphoma

A. Hekman, E. Rankin, R. Somers, 1985 .

The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.

O. Nieweg, E. Rankin, J. Bonfrer, 1998, British Journal of Cancer.

Observations on the toxicity of the combination of gentamicin and mezlocillin in the treatment of patients with acute leukaemia.

E. Rankin, J. Howard Scarffe, D. M. Jones, 1984, The Journal of antimicrobial chemotherapy.

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

J. Verweij, A. Santoro, H. Mouridsen, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

H. Kitchener, S. Stacey, T. Bauknecht, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

VAC (vincristine, adriamycin, cyclophosphamide) chemotherapy for metastatic carcinoma from an unknown primary site.

D. Crowther, N. Thatcher, J. Wagstaff, 1983, European journal of cancer & clinical oncology.

Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients.

A. Berns, M. Gallee, W. Mooi, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recombinant interleukin-2 in cancer: basic and clinical aspects.

L. T. Vlasveld, E. Rankin, 1994, Cancer treatment reviews.

Prophylactic cranial irradiation in extensive small-cell lung cancer.

L. Collette, P. Postmus, C. Faivre-Finn, 2007, The New England journal of medicine.

Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer

I. Vergote, J. Keck, C. Runowicz, 2010, International Journal of Gynecologic Cancer.

Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.

W. Gregory, P. Johnson, W. Qian, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

IN SILICO PREDICTION OF DRUG BINDING TO CYP2D6: IDENTIFICATION OF A NEW METABOLITE OF METOCLOPRAMIDE

Gordon C K Roberts, Simon J Brown, Jean-Didier Maréchal, 2006, Drug Metabolism and Disposition.

In Silico Prediction of Drug Binding to Cytochrome P450 2D6: Identification of a new Metabolite of Metoclopramide

Simon J Brown, M. Sutcliffe, Jean‐Didier Maréchal, 2006 .

Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups.

Andrew Bottomley, Suresh Senan, Corinne Faivre-Finn, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Temozolomide for the treatment of brain metastases associated with metastatic melanoma: a phase II study.

M. Gore, J. Kirkwood, A. Buzaid, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985.

D. Kerr, K. Calman, S. Kaye, 1988, British Journal of Cancer.

Detection of early micrometastases in malignant melanoma.

E. Rankin, 1996, European journal of cancer.

Immunomodulation following vaccination with autologous, GM-CSF transduced and irradiated tumor cells in patients with advanced melanoma

M. Gallee, H. Spits, E. Rankin, 1997 .

Phase II study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancer.

A. C. Dubbelman, S. Horenblas, A. Hekman, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19

J. Sein, A. Hekman, C. Melief, 2005, Cancer Immunology, Immunotherapy.

A phase II study of 4-deoxydoxorubicin in advanced breast cancer.

R. K. Knight, R. Rubens, E. Rankin, 1987, European journal of cancer & clinical oncology.

A. C. Dubbelman, S. Rodenhuis, E. Rutgers, 1994, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial.

S. Kaye, N. Reed, R. Jones, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I and Pharmacokinetic Study of Flavone Acetic Acid1

Christopher, S. Kaye, G. Forrest, 2006 .

Phase I and Pharmacokinetic Study of Flavone Acetic Acid 1

D. Kerr, S. Kaye, J. Cassidy, 2006 .

Dynamic studies of lymphocytes labelled with indium-111 during and after treatment with monoclonal anti-idiotype antibody in advanced B cell lymphoma.

A. Hekman, C. Hoefnagel, M. Hardeman, 1984, British medical journal.

Ophthalmic toxicity during carboplatin therapy.

E. Rankin, J. Pitts, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Radioimmunodetection ofcancer:problems andpotential

E. Rankin, J. Gordon, 1983 .